Navigation Links
Vanderbilt Experts For Health Care Debate
Date:9/9/2009

mong the nation's most prominent scholars of health law, law and medicine and voting rights. As founder of the Vanderbilt Institute for Public Policy Studies and director of its Health Policy Center, Blumstein served as the principal investigator on numerous grants concerning managed care, hospital management and medical malpractice. He co-authored a major study on TennCare, one of the first statewide experiments in enrolling Medicaid patients in managed care.

Bruce Oppenheimer, professor of political science

Oppenheimer researches the legislative process, political parties and congressional elections. He co-authored the award-winning book Sizing Up the Senate: The Unequal Consequences of Equal Representation.

Oppenheimer can discuss the complex strategies behind passing a health care bill and the strategic game between the White House and GOP.


'/>"/>
SOURCE Vanderbilt University
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Vanderbilt nets brain gene research center
2. Vanderbilt Medical Center chosen as Evidence-based Practice Center
3. Vanderbilt University Medical Center and Waters Collaborate on Tissue Imaging Research Using SYNAPT HDMS
4. NIH-funded Vanderbilt Research Seeks Ways to Avoid Information Overload in Health Care Choices Among Seniors
5. Vanderbilt researchers pioneer an advanced sepsis detection and management system
6. Vanderbilt joins national consortium to develop new cancer therapies
7. Research Links TV/Video Game Playing With Child Obesity; Health Experts Back a New Approach
8. MultiVu Video Feed: PUBLIC HEALTH EXPERTS CONVENE TO DISCUSS THE TREATMENT AND PREVENTION OF RABIES
9. Health IT Event Draws Experts to the Pacific Northwest
10. Experts Sort Out Good Fats From Bad
11. Experts Offer Tips on Lung Cancer Prevention
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... California, San Diego School of Medicine report that older ... recent major loss are more likely to be compassionate ... is published in this month,s issue of the ... behaviors are associated with better health and well-being as ... to improve the outcomes of individuals whose deficits in ...
(Date:4/17/2014)... NY In a review published in the April ... president of The Feinstein Institute for Medical Research, says ... medical community,s approach to treating sepsis, which ... Americans. , Sepsis occurs when molecules released into the ... throughout the body. Inflammation is necessary for maintaining good ...
(Date:4/17/2014)... A Northwestern University synthetic biology team has created ... create programmable therapeutics that could travel the body ... disease. , Engineering cell-based, biological devices that monitor ... in clinical synthetic biology. However, no existing technology ... a patient,s physiological state and respond in a ...
(Date:4/17/2014)... MAYWOOD, Il. (April 17, 2014) Doctors who ... disease called lymphangioleiomyomatosis (LAM) can face an agonizing ... progression of the disease and help relieve shortness ... lung transplants, and sirolimus can cause potentially fatal ... said pulmonologist Dr. Daniel Dilling, medical director of ...
(Date:4/17/2014)... The cause of neuronal death in Parkinson,s disease is ... may be mistaken for foreign invaders and killed by ... autoimmune diseases like type I diabetes, celiac disease, and ... published April 16, 2014, in Nature Communications . ... in Parkinson,s disease; but if true, it could lead ...
Breaking Medicine News(10 mins):Health News:The ilk of human kindness 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2Health News:Building 'smart' cell-based therapies 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:Is Parkinson's an autoimmune disease? 2
... growth worsens ovarian cancer, but its production can be stifled ... nanoparticle, a research team led by scientists at The University ... Journal of the National Cancer Institute. , "The protein interleukin-8 ... senior author Anil Sood, M.D., professor in the M. D. ...
... Works to Help Hollywood ,Stay Sane in an Insane ... ... Roy, M.A., "The,Industry Therapist" ( http://www.theIndustryTherapist.com ) is asking the,question why the ... Spears, mental illness., "Heath Ledger,s death is being treated with kid ...
... Feb. 26 Hologic, Inc.,(Nasdaq: HOLX ) today ... at the Raymond James & Associates 29th Annual,Institutional Investors ... Grand Cypress Hotel in Orlando, FL., Interested parties ... of,Hologic,s investor presentation on Monday, March 3, 2008 at ...
... clots, study says, , , TUESDAY, Feb. 26 (HealthDay News) ... associated with cancer treatment-related anemia may do more harm ... , The drugs -- erythropoiesis-stimulating agents (ESAs) -- increase ... risk of blood clots known as venous thromboembolisms (VTE) ...
... Increased ... 3.85% and 2.96%, Respectively, MEXICO CITY, Feb. 26 ... one of the leading Mexican,distributors of pharmaceutical products, beauty aids, ... its consolidated financial and operating results for the fourth,quarter of ...
... 26 Schnitzer West announced today,that one of the ... Coast gym in The Shops at The Bravern in ... time to meet the needs of approximately 2,300,Microsoft employees ... of the,project beginning this fall., DavidBartonGym will offer ...
Cached Medicine News:Health News:Researchers identify and shut down protein that fuels ovarian cancer 2Health News:Researchers identify and shut down protein that fuels ovarian cancer 3Health News:Hologic to Present at the Raymond James & Associates 29th Annual Institutional Investors Conference 2Health News:Anemia Drugs for Cancer Patients Increase Death Risk 2Health News:Anemia Drugs for Cancer Patients Increase Death Risk 3Health News:Grupo Casa Saba Announces Fourth Quarter 2007 Results 2Health News:Grupo Casa Saba Announces Fourth Quarter 2007 Results 3Health News:Grupo Casa Saba Announces Fourth Quarter 2007 Results 4Health News:World-Famous DavidBartonGym Buffs up the Bravern 2Health News:World-Famous DavidBartonGym Buffs up the Bravern 3
(Date:1/15/2014)... , Jan. 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ... its Symphony® CGM System as a non-invasive, wireless continuous ... Doman , Executive Chairman and Interim CEO of Echo ... Tenth Annual Equity Conference. Mr. Doman ...
(Date:1/15/2014)... 2014 Reportlinker.com announces that a new ... catalogue: PharmaPoint: Atopic ... Analysis to 2022 http://www.reportlinker.com/p01957657/PharmaPoint-Atopic-Dermatitis---India-Drug-Forecast-and-Market-Analysis-to-2022.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology ... India Drug Forecast and Market Analysis to ...
(Date:1/15/2014)... , Jan. 15, 2014  Zafgen, Inc., a leading ... of severely obese patients, today announced initial results ... selective inhibitor of methionine aminopeptidase 2 (MetAP2), in ... of genetic obesity.  These results showed improvements in ...
Breaking Medicine Technology:Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4
... Walmart (NYSE: WMT ) and Eli Lilly and Company ... affordable insulin option for people with diabetes.   , ... Beginning in mid-September, Lilly,s Humulin ® brand of ... name Humulin ® ReliOn ®, including 10 mL vials of Humulin® ...
... NASHVILLE, Tenn. , June 21 Emdeon Inc. (NYSE: ... payment cycle management solutions, today announced the acquisition of Chapin Revenue ... is a leading technology-enabled provider of hospital-based revenue cycle services including ... , , ...
Cached Medicine Technology:Walmart, Lilly Team Up to Provide Human Insulin to People With Diabetes 2Walmart, Lilly Team Up to Provide Human Insulin to People With Diabetes 3Walmart, Lilly Team Up to Provide Human Insulin to People With Diabetes 4Walmart, Lilly Team Up to Provide Human Insulin to People With Diabetes 5Emdeon Acquires Chapin to Enhance Provider-Focused Payment Integrity 2Emdeon Acquires Chapin to Enhance Provider-Focused Payment Integrity 3Emdeon Acquires Chapin to Enhance Provider-Focused Payment Integrity 4
... This unique system uses prolene as thread-guide ... The hollow Ritleng Probe is inserted into the ... fed through it. The probe is then withdrawn ... mm 0.64 mm diam silicone tubing into place. ...
To maintain the conjunctival cul-de-sacs after enucleation or evisceration without hindering lid closure....
... collarette conforms to natural anatomy of ... Pre-loaded on disposable inserter/dilator instrument for ... forceps. The Micro-Large plugs feature the ... natural shape of the eyelid. The ...
With side bite Instrument recommended to catch the polypropylene thread in the nose....
Medicine Products: